235 related articles for article (PubMed ID: 8589788)
1. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
[TBL] [Abstract][Full Text] [Related]
2. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
3. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
4. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
5. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
Kitagawa N; Yano Y; Gabazza EC; Bruno NE; Araki R; Matsumoto K; Katsuki A; Hori Y; Nakatani K; Taguchi O; Sumida Y; Suzuki K; Adachi Y
Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
[TBL] [Abstract][Full Text] [Related]
6. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
9. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
[TBL] [Abstract][Full Text] [Related]
10. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
[TBL] [Abstract][Full Text] [Related]
12. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
13. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
15. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
16. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
Kishore P; Li W; Tonelli J; Lee DE; Koppaka S; Zhang K; Lin Y; Kehlenbrink S; Scherer PE; Hawkins M
Sci Transl Med; 2010 Feb; 2(20):20ra15. PubMed ID: 20371491
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.
Båvenholm PN; Kuhl J; Pigon J; Saha AK; Ruderman NB; Efendic S
J Clin Endocrinol Metab; 2003 Jan; 88(1):82-7. PubMed ID: 12519834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
